Epidemiological study of opioid use disorder in French emergency departments, 2010-2018 from OSCOUR database
- PMID: 33127629
- PMCID: PMC7604823
- DOI: 10.1136/bmjopen-2020-037425
Epidemiological study of opioid use disorder in French emergency departments, 2010-2018 from OSCOUR database
Abstract
Objectives: Opioid consumption in France has remained stable over the last 15 years, with much lower levels than in the USA. However, few data are available on patients who consume opioids and their use of the health system. Emergency department (ED) data has never been used as a source to investigate opioid use disorder (OUD) in France.
Design/settings/participants: We used the OSCOUR national surveillance network, collecting daily ED data from 93% of French ED, to select and describe visits and hospitalisations after an OUD-related ED visit between 2010 and 2018 using International Classification of Diseases, version 10 (ICD10) codes. We described the population of interest and used binomial negative regressions to identify factors significantly associated with OUD such as gender, age, administrative region, year of admission and ICD10 codes. We also analysed the related diagnoses.
Primary outcome measure: Trend in ED visits for an OUD-related ED visit.
Results: We recorded 34 362 OUD-related visits out of 97 892 863 ED visits (36.1/100 000 visits). OUD-related visits decreased from 39.2/100 000 visits in 2010 to 32.9/100 000 visits in 2018, resulting in an average yearly decrease of 2.1% (95% CI 1.5% to 2.7%) after multivariate analysis. We recorded 15 966 OUD-related hospitalisations out of 20 359 574 hospitalisations after ED visits (78.4/100 000 hospitalisations) with an increase from 74.0/100 000 hospitalisations in 2010 to 81.4/100 000 hospitalisations in 2018. The analysis of related diagnoses demonstrated mostly polydrug abuse in this population.
Conclusions: While the proportion of OUD visits decreased in the time frame, the hospitalisation proportion increased. The implementation of a nationwide surveillance system for OUD in France using ED visits would provide prompt detection of changes over time.
Keywords: accident & emergency medicine; epidemiology; health informatics; substance misuse.
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures



Similar articles
-
Hospital and physician-based mental healthcare during 12 months of opioid agonist treatment for opioid use disorder: Exploring costs and factors associated with acute care.PLoS One. 2025 Jan 8;20(1):e0314296. doi: 10.1371/journal.pone.0314296. eCollection 2025. PLoS One. 2025. PMID: 39775273 Free PMC article.
-
Emergency department presentation of opioid use disorder and alcohol use disorder.J Subst Abuse Treat. 2021 Aug;127:108343. doi: 10.1016/j.jsat.2021.108343. Epub 2021 Mar 3. J Subst Abuse Treat. 2021. PMID: 34134862
-
Variation in emergency department visit rates for opioid use disorder: Implications for quality improvement initiatives.Am J Emerg Med. 2022 Jan;51:331-337. doi: 10.1016/j.ajem.2021.10.047. Epub 2021 Nov 9. Am J Emerg Med. 2022. PMID: 34800906
-
Beyond Buprenorphine: Models of Follow-up Care for Opioid Use Disorder in the Emergeny Department.West J Emerg Med. 2020 Nov 2;21(6):257-263. doi: 10.5811/westjem.2020.7.46079. West J Emerg Med. 2020. PMID: 33207174 Free PMC article. Review.
-
Approach to buprenorphine use for opioid withdrawal treatment in the emergency setting.Am J Emerg Med. 2019 Jan;37(1):143-150. doi: 10.1016/j.ajem.2018.10.013. Epub 2018 Oct 11. Am J Emerg Med. 2019. PMID: 30355476 Review.
Cited by
-
Methadone Dose and Timing of Administration as Predictors of Sleep Apnea Syndrome During Methadone Maintenance Treatment: A Retrospective Cross-sectional Study.Addict Health. 2023 Oct;15(4):240-246. doi: 10.34172/ahj.2023.1455. Epub 2023 Oct 29. Addict Health. 2023. PMID: 38322484 Free PMC article.
-
Abuse, dependence and withdrawal associated with fentanyl and the role of its (designated) route of administration: an analysis of spontaneous reports from Europe.Eur J Clin Pharmacol. 2023 Feb;79(2):257-267. doi: 10.1007/s00228-022-03431-x. Epub 2022 Dec 16. Eur J Clin Pharmacol. 2023. PMID: 36525039 Free PMC article.
References
-
- CDC opioid V1 | Knowledge repository. Available: https://www.surveillancerepository.org/cdc-opioid-v1 [Accessed 1 Jul 2019].
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical